Hormones in the naso-oropharynx: endocrine modulation of taste and smell
Genetics can affect appetite signaling, cravings, satiety, insulin response, fat storage tendencies, energy balance, inflammation, and how the body responds to certain metabolic interventions
Industry research also shows that demand for GLP-1 programs is exploding in 2025
Evidence from the SURPASS phase III clinical trial program has consistently demonstrated the superior metabolic efficacy of tirzepatide compared with currently available GLP-1 receptor agonists, such as semaglutide
This plan involves a variety of interventions, such as dietary changes, regular physical activity, and consistent support from healthcare providers